These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 7102691)

  • 1. Antibiotics standards versus standards for other drugs.
    Wright WW
    Am J Hosp Pharm; 1982 Jun; 39(6):1046-7. PubMed ID: 7102691
    [No Abstract]   [Full Text] [Related]  

  • 2. Generic vs. brand name drugs--defining and enforcing standards.
    Lasagna LC
    Internist; 1979 May; 20(4):11, 13. PubMed ID: 10316827
    [No Abstract]   [Full Text] [Related]  

  • 3. Improving drug quality through certification experience.
    Weiss PJ
    Am J Pharm Sci Support Public Health; 1974; 146(3):86-90. PubMed ID: 4852375
    [No Abstract]   [Full Text] [Related]  

  • 4. New York State and drug lists: a history of confusion.
    Stetler CJ
    Med Mark Media; 1978 Sep; 13(9):36, 38, 40 passim. PubMed ID: 10316687
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug development--1970.
    De Haen P
    N Y State J Med; 1971 Apr; 71(8):889-94. PubMed ID: 5279361
    [No Abstract]   [Full Text] [Related]  

  • 6. New classification of drugs.
    J Fla Med Assoc; 1972 Jan; 59(1):37. PubMed ID: 5058956
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs, codes, standards, and other incompatible things in the dark.
    Chute CG
    MD Comput; 2001; 18(1):45-6. PubMed ID: 11236386
    [No Abstract]   [Full Text] [Related]  

  • 8. Counterfeit drugs.
    Rudolf PM; Bernstein IB
    N Engl J Med; 2004 Apr; 350(14):1384-6. PubMed ID: 15070787
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulating drugs for effectiveness and safety: a public health perspective.
    Zito JM; Socolar SJ; Eilers R; Crystal S; Lexchin J
    Med Care; 2007 Sep; 45(9):911. PubMed ID: 17712264
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug standards and the dental practitioner.
    Feldmann EG
    J Oral Ther Pharmacol; 1965 Nov; 2(3):224-8. PubMed ID: 5849261
    [No Abstract]   [Full Text] [Related]  

  • 11. Benefits and liabilities of generic prescribing.
    Lee AM
    W V Med J; 1972 Jun; 68(6):161-6. PubMed ID: 4504384
    [No Abstract]   [Full Text] [Related]  

  • 12. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract]   [Full Text] [Related]  

  • 13. Public standards for drugs: reflections on their use by the professions and industry.
    Miller LC
    Hosp Formul; 1976 Mar; 11(3):151-5. PubMed ID: 1026682
    [No Abstract]   [Full Text] [Related]  

  • 14. Curbing counterfeit drugs.
    FDA Consum; 2006; 40(5):11. PubMed ID: 17326307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of drug standards.
    Heller WM
    Am J Hosp Pharm; 1982 Apr; 39(4):652-3. PubMed ID: 7081247
    [No Abstract]   [Full Text] [Related]  

  • 16. "Who shall establish drug standards"?
    Macek TJ
    J Am Pharm Assoc; 1973 Mar; 13(3):122-3. PubMed ID: 4689929
    [No Abstract]   [Full Text] [Related]  

  • 17. Current trends in IND-NDA procedures.
    Brilhart KB
    Bull Parenter Drug Assoc; 1971; 25(3):132-9. PubMed ID: 5093249
    [No Abstract]   [Full Text] [Related]  

  • 18. Should the FDA impose relative efficacy judgments?
    Stetler CJ
    Tex Med; 1972 Nov; 68(11):48-52. PubMed ID: 4634627
    [No Abstract]   [Full Text] [Related]  

  • 19. The control of drugs and therapeutic freedom.
    Dunlop D
    Proc R Soc Med; 1968 Aug; 61(8):841-6. PubMed ID: 5695368
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug standards laboratory enters second decade.
    Reese KM
    J Am Pharm Assoc; 1972 Jan; 12(1):16-20. PubMed ID: 5007258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.